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Process Analytical Technology (PAT) involves the timely analysis of Critical Quality Attributes (CQAs) and 
Critical Process Parameters (CPPs) with the aim to improve the process control strategy resulting in a better 
process performance and robust product quality. The progress of PAT implementation in upstream 
bioprocessing has been slow mainly due to the complexity of the process steps with many parameters involved, 
and the complexity of the product and the culture medium. While the first approved PAT-based Real Time 
Release application in the small molecules field already celebrating its 10th anniversary in 2016, PAT for 
upstream bioprocessing is only now maturing.  
 
This paper will discuss the considerations and constraints during design, construction and early operation of a 
PAT system at MSD in Oss (Part of Merck & Co), The Netherlands. A four-stage strategy is adopted. The first 
stage brings routine in process analyses online. This is achieved by linking an auto-sampler to a cell counter 
and a nutrient analyzer. This setup will already reduce manual sampling needs and increase process 
understanding. In the second stage these online nutrient measurements are used to control feeding at a target 
glucose concentration (feedback control loop). In the third stage online CQA measurements on the cell 
containing culture broth are added to gain high resolution information on CQA evolution during the culture 
process. In the fourth stage online spectroscopic tools are added to replace sample-based methods such as 
nutrient analysis and cell counts. In parallel an IT infrastructure is built to support online data modelling and 
model-based feedback control. The final system is very advanced in its kind and will potentially have real time 
release capability for the upstream harvest. This strategy, the system design and layout of the PAT 
infrastructure at MSD in Oss will be presented as well as experimental results and system performance data. 
